Narcolepsy Patients Hope FDA Attention Will Spur Drug Research, Shed Misperceptions
Executive Summary
Narcolepsy community will tell FDA about the need for new treatments at a patient-focused drug development initiative meeting; research is under way to replace the chemical in the brain that regulates sleep and wakefulness, which a leading researcher likens to insulin for type 1 diabetes.